anx_II__para_3__continuation__27
91/666/EEC: Council Decision of 11 December 1991 establishing Community reserves of foot-and-mouth disease vaccines · European Union
The producer should also specify the expected shelf-life of the product after formulation into vaccine. This shelf-life should be at least four months.
← anx_II__para_3__continuation__26 · All articles · anx_II__para_3__continuation__28 →
Source: EUR-Lex (Cellar) · retrieved 2026-11-08 · Text as adopted (Official Journal); later amendments are not incorporated in this text.